Meijer, R. P.
Funding for this research was provided by:
University Medical Center Utrecht
Article History
Accepted: 3 September 2021
First Online: 8 October 2021
Declarations
:
: R. P. Meijer is member of the board of ProBCI, a Dutch national bladder cancer infrastructure that is sponsored by unrestricted grants from BMS, Janssen, AstraZeneca, Astellas, and MSD.
: The investigations were carried out according to the specifications of the Central Ethics Committee of the Federal Medical Council.
: The supplement containing this article is not sponsored by industry